| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |